NCT06903676 Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
| NCT ID | NCT06903676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Pancreatitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-08-05 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.
Eligibility Criteria
Inclusion Criteria: * Older than 18 years of age * Undergoing elective pancreatectomy for any indication Exclusion Criteria: * Younger than 18 years of age * Pregnant women * Prisoner
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06903676 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pancreatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06903676 currently recruiting?
Yes, NCT06903676 is actively recruiting participants. Contact the research team at nzyromski@iu.edu for enrollment information.
Where is the NCT06903676 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT06903676 clinical trial?
NCT06903676 is sponsored by Indiana University. The trial plans to enroll 50 participants.